Procter & Gamble, US7427181091

Procter & Gamble heads into results. Procter & Gamble stock loses 1.06 percent

Published on 10/16/2026 at 09:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
P&G reports first-quarter fiscal 2027 results October 22, 2026. Procter & Gamble stock costs EUR 140.27 on October 16, 2026, 1.06 percent below Xetra close.

Results and operating pressure

  • First-quarter fiscal 2027 results are scheduled for October 22, 2026.
  • Fiscal 2026 net sales reached USD 87.0 billion, while organic sales growth was 1 percent.
  • Procter & Gamble stock trades at EUR 140.27 at 9:45 a.m. CEST at Lang & Schwarz on October 16, 2026, 1.06 percent below the Xetra close of October 15, 2026.
  • The quarterly dividend of USD 1.09 is scheduled for payment on November 16, 2026.
Procter Lieferkette US7427181091 als isometrische 3D Illustration eines modernen Lagerzentrums mit Gabelstaplern und Lastwagen, Illustration mit AI erstellt.

Procter & Gamble (ISIN US7427181091) stock was trading at EUR 140.27 at Lang & Schwarz on October 16, 2026 at 9:45 a.m. CEST, down 1.06 percent versus the Xetra close of October 15, 2026 at EUR 141.78. The company is approaching its first-quarter fiscal 2027 results, with the next report scheduled for October 22, 2026, according to Business Wire on September 24, 2026.

Results will test earnings resilience

The upcoming quarter is expected to show a mixed operating picture. Yahoo Finance reported on October 15, 2026 that the consensus forecast calls for quarterly earnings of USD 1.89 per share, down 5 percent from the year-earlier period, while revenue is expected to rise 1.4 percent to USD 22.7 billion. The estimate puts earnings pressure ahead of the report even as sales remain on a modest growth path.

What do operating figures imply?

Procter & Gamble's fiscal 2026 results provide the latest reported baseline. The company recorded USD 87.0 billion in net sales, up 3 percent, and USD 16.0 billion in net income attributable to common shareholders, compared with USD 15.97 billion in fiscal 2025, according to the company's investor-relations information. Operating cash flow reached USD 19.6 billion in fiscal 2026, up from USD 17.8 billion in the prior fiscal year. The combination of sales growth and higher cash generation gives the quarterly report a concrete test: whether volume and profitability can keep pace with pricing.

Zacks wrote on September 21, 2026 that organic sales increased 1 percent in fiscal 2026, with pricing contributing one percentage point, while fourth-quarter volume rounded down to flat. The same analysis cited a USD 1.4 billion after-tax earnings headwind expected in fiscal 2027, making cost control a central issue for the new reporting year.

Three dates frame the stock

On July 29, 2026, Procter & Gamble reported fourth-quarter earnings of USD 1.43 per share against a USD 1.41 consensus estimate, while quarterly revenue was USD 21.20 billion, according to MarketBeat. On September 21, 2026, Zacks assessed fiscal 2026 organic sales growth at 1 percent and cited the projected USD 1.4 billion fiscal 2027 headwind. On September 24, 2026, Business Wire reported the October 22 results webcast and its 8:30 a.m. ET start.

Dates investors can measure

The next reporting date is October 22, 2026, with the discussion scheduled for 8:30 a.m. ET. The quarterly dividend of USD 1.0885 per share is scheduled for payment on November 16, 2026 to shareholders of record on October 23, 2026, as reported by MarketBeat. These dates place earnings execution before the next cash-return milestone.

Stock stays below the Xetra close

On the primary exchange, the stock was last quoted at USD 157.06 on October 15, 2026 at 3:59 p.m. ET. The same market data showed a 52-week range of USD 137.62 to USD 167.25 and a market capitalization of USD 364.8 billion. The euro quote was 1.06 percent below the Xetra close while the company prepared for a report centered on sales growth, volume and cost pressure.

The further course of trading is shown by the continuously updated real-time quote of Procter & Gamble stock.

Procter & Gamble stock facts

  • Company: The Procter & Gamble Company
  • ISIN: US7427181091
  • Ticker: PG
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 16, 2026, 9:45 a.m. CEST): EUR 140.27
  • Change versus Xetra close: minus 1.06 percent
  • Xetra close (October 15, 2026): EUR 141.78
  • Market capitalization: USD 364.8 billion (as of October 15, 2026)
  • 52-week range: USD 137.62-167.25 (as of October 15, 2026)
  • Sector / Industry: Consumer Defensive / Household & Personal Products

Market context: Market report S&P 500.

More news and analyses on Procter & Gamble stock

Disclaimer...
en | US7427181091 | PROCTER & GAMBLE | boerse | 70337675 | bgmi